Hypermethioninemia
Sep. 12, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Bacillus anthracis produces the three subunits of anthrax toxin: protective antigen (PA), lethal factor (LF) and edema factor (EF). The 83 kDa form of PA (PA83) binds to either of two type I transmembrane proteins (CMG2 or TEM8) at the cell surface, where it is cleaved by furin-like proteases, leading to the shorter receptor-associated form of PA (PA63) and a soluble fragment (PA20). Upon toxin binding, the receptors are phosphorylated by Src‐like kinases (Src or Fyn), and are ubiquitinated (by Cbl for TEM8, or by an unknown E3 ligase for CMG2). After oligomerization in lipid rafts (dark grey), the receptor-toxin complex is internalized by endocytosis, a process involving clathrin, dynamin, activator protein 1 (AP‐1), actin, and low-density lipoprotein receptor-related protein 6 (LRP6). (Source: Friebe S, van der Goot FG, Bürgi J. The ins and outs of anthrax toxin. Toxins (Basel) 2016;8(3). Creative Commons by Attribution (CC-BY) License.)